A provider tells you "draw 10 units." You draw 10 units
Cotten was so sweet and explained everything to me
Why Patients Use NAD+ During Tirzepatide Therapy During the early weeks of Tirzepatide, many patients describe feeling lighter but tired. This is usually due to decreased calorie intake, changes in blood sugar patterns, and the body shifting fuel sources
Clinical Evidence: What Studies Show About GLP-1 and Heart Health The SUSTAIN-6 trial, a landmark study published in 2016, examined semaglutide's cardiovascular effects in people with type 2 diabetes and existing heart disease or high risk
Under the first phase of the ongoing two part study, the drug demonstrated "statistically significant improvement in liver fibrosis and resolution of steatohepatitis compared to placebo." In August 2025, the company received final approval to market the therapy for the additional indication in the US, followed by a conditional approval in Canada in December